Show simple item record

dc.contributor.authorLynch, FA
dc.contributor.authorKatona, L
dc.contributor.authorJefford, M
dc.contributor.authorBen Smith, A
dc.contributor.authorShaw, J
dc.contributor.authorDhillon, HM
dc.contributor.authorEllen, S
dc.contributor.authorPhipps-Nelson, J
dc.contributor.authorLai-Kwon, J
dc.contributor.authorMilne, D
dc.contributor.authorRussell, L
dc.contributor.authorDax, V
dc.contributor.authorDiggens, J
dc.contributor.authorKent, H
dc.contributor.authorButton-Sloan, A
dc.contributor.authorElliott, J
dc.contributor.authorShackleton, M
dc.contributor.authorBurridge, H
dc.contributor.authorFtanou, M
dc.date.accessioned2020-11-17T03:45:49Z
dc.date.available2020-11-17T03:45:49Z
dc.date.issued2020-09-01
dc.identifierpii: jcm9092969
dc.identifier.citationLynch, F. A., Katona, L., Jefford, M., Ben Smith, A., Shaw, J., Dhillon, H. M., Ellen, S., Phipps-Nelson, J., Lai-Kwon, J., Milne, D., Russell, L., Dax, V., Diggens, J., Kent, H., Button-Sloan, A., Elliott, J., Shackleton, M., Burridge, H. & Ftanou, M. (2020). Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma. JOURNAL OF CLINICAL MEDICINE, 9 (9), https://doi.org/10.3390/jcm9092969.
dc.identifier.issn2077-0383
dc.identifier.urihttp://hdl.handle.net/11343/251593
dc.description.abstractImmunotherapies and targeted therapies have revolutionised treatment of metastatic melanoma and improved survival rates. However, survivors treated with novel therapies are vulnerable to high levels of fear of cancer recurrence or progression (FCR). Existing FCR interventions have rarely been trialled in people with advanced cancer. The current study aimed to evaluate the acceptability and feasibility of Fear-Less: a stepped-care model to treat FCR in people with metastatic melanoma treated with immunotherapy or targeted therapy. Sixty-one outpatients with metastatic melanoma were screened using the Fear of Cancer Recurrence Inventory Short Form (FCRI-SF) and Fear of Progression Questionnaire Short Form (FoP-Q-SF). Survivors with subthreshold FCR were stratified to a self-management intervention while those with clinical levels of FCR were provided with an individual therapy, Conquer Fear. Survivor experience surveys and rescreening were administered post-intervention completion. Results indicated that Fear-Less was an acceptable and feasible FCR intervention. Results provided preliminary support for the potential impact of Fear-Less in reducing FCR. Fear-Less is a promising first step in providing an acceptable and feasible stepped-care model to treat FCR in survivors with metastatic disease.
dc.languageEnglish
dc.publisherMDPI
dc.titleFeasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma
dc.typeJournal Article
dc.identifier.doi10.3390/jcm9092969
melbourne.affiliation.departmentPsychiatry
melbourne.affiliation.departmentMicrobiology and Immunology
melbourne.source.titleJournal of Clinical Medicine
melbourne.source.volume9
melbourne.source.issue9
dc.rights.licenseCC BY
melbourne.elementsid1465620
melbourne.contributor.authorEllen, Steven
melbourne.contributor.authorLynch, Fiona
dc.identifier.eissn2077-0383
melbourne.accessrightsOpen Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record